Clever Way Global Limited holds 498,922 Class A ordinary shares in Universe Pharmaceuticals INC, equal to 9.96% of the class. The position is passive, and the holder and Lu Yang say the shares were not acquired or held to change or influence control, a relevant distinction for UPC investors assessing Shareholder intentions.
Key Highlights
- Lu Yang wholly owns and controls Clever Way Global Limited, which holds the reported position.
- Clever Way Global Limited and Lu Yang signed a joint filing agreement on Sep 1, 2026.
- Clever Way Global Limited holds 498,922 Class A ordinary shares of Universe Pharmaceuticals INC, representing a reported 9.96% position.
- The position is classified under Rule 13d-1(c), and the holders state it was not acquired or held to influence control.
Universe Pharmaceuticals INC (NASDAQ: UPC) has a 9.96% shareholder position held through 498,922 Class A ordinary shares by Clever Way Global Limited.
Clever Way Holds Class A Shares
Clever Way Global Limited’s reported position consists entirely of Class A ordinary shares. Lu Yang is associated with the same 498,922-share position through his ownership and control of the company. The reported 9.96% stake therefore represents the proportion of that Share Class attributed to both Clever Way Global Limited and Lu Yang. The ownership records identify Clever Way Global Limited as a Limited Liability company formed in the British Virgin Islands. Its listed address is in Road Town, Tortola, British Virgin Islands, while Lu Yang’s address is in Xiamen, Fujian Province, People's Republic of China. The passive classification distinguishes the reported ownership from an expressly stated control-change purpose.
Joint Agreement Signed Sep 1
Lu Yang signed for Clever Way Global Limited as director and also signed in his individual capacity. The joint filing agreement was executed on Sep 1, 2026. The ownership statement identifies both reporting persons with 498,922 shares and 9.96% ownership.
FAQs
Q: Who owns 9.96% of Universe Pharmaceuticals INC?
A: Clever Way Global Limited holds 498,922 Class A ordinary shares of Universe Pharmaceuticals INC. Lu Yang wholly owns and controls Clever Way Global Limited and is listed with the same position.
Q: Is Clever Way Global Limited an activist investor in UPC?
A: The ownership position is classified as passive under Rule 13d-1(c). The holders state that the shares were not acquired or held to change or influence Universe Pharmaceuticals INC’s control.
Q: What shares does Clever Way Global Limited hold in Universe Pharmaceuticals INC?
A: Clever Way Global Limited holds 498,922 Class A ordinary shares of Universe Pharmaceuticals INC, representing a reported 9.96% position. The shares were not acquired or held to influence control.
Q: How is Lu Yang connected to the reported position?
A: Lu Yang is associated with the same 498,922-share position through ownership and control of Clever Way Global Limited. He also signed the statement in his individual capacity.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.